Friedreich ataxia
- Omaveloxolone slows disease progression in eligible patients
- Physical/occupational therapy preserves function
- Treat cardiomyopathy, diabetes + scoliosis complications
- Mobility/assistive devices are often needed
- Monitor liver/lipid effects with omaveloxolone
- No therapy reverses established neurologic injury
Use at a glance
- Omaveloxolone slows disease progression in eligible patients
Treatment options
- Physical/occupational therapy preserves function
- Treat cardiomyopathy, diabetes + scoliosis complications
Other treatment options
- Mobility/assistive devices are often needed
- No therapy reverses established neurologic injury
Monitoring / follow-up
- Monitor liver/lipid effects with omaveloxolone
Self-check
- Does therapy reverse established Friedreich neurologic injury?
No. - What is monitored with omaveloxolone?
Liver/lipid effects with omaveloxolone.
Drugs used for this (1)
All clinical uses · Open Friedreich ataxia in the interactive console ↗